Lexeo Therapeutics Inc

NAS:LXEOHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$2.76+4.55%At closeAt close · Tue 20 Oct · ≈ AED 10.14 · Market cap $226.45M · Next earnings Mon 14 Dec

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	100.0%	100.0%	100.0%	—	—	—	—	—
Operating margin	−884.9%	−3,055.9%	−9,252.1%	—	—	—	—	—
Net margin	−993.8%	−3,055.0%	−9,063.8%	—	—	—	—	—
EBITDA margin	−884.9%	−3,054.3%	−8,874.8%	—	—	—	—	—
Return on equity	93.1%	91.0%	52.5%	−58.5%	−84.2%	−40.5%	−40.5%	+0.0 pts
Return on assets	−17.5%	−37.0%	−61.1%	−47.5%	−66.9%	−37.2%	−37.2%	+0.0 pts
Return on capital employed	−16.0%	−39.1%	−73.1%	−55.9%	−85.2%	−43.4%	—	—
Debt / equity	0.0×	0.0×	−0.1×	0.1×	0.1×	0.0×	0.0×	+0.0%
Debt / assets	0.0%	0.0%	13.9%	8.3%	6.8%	2.9%	—	—
Interest coverage	−31.2×	0.0×	−664.9×	−334.2×	−927.8×	−530.4×	—	—
Current ratio	42.1×	18.3×	5.6×	7.2×	5.5×	11.2×	11.2×	+0.0%
Quick ratio	42.1×	18.3×	5.6×	7.2×	5.5×	11.2×	—	—
Cash ratio	42.1×	18.2×	5.4×	7.0×	1.5×	3.7×	3.7×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.